Publication | Closed Access
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study
226
Citations
27
References
2019
Year
OncologyGastrointestinal OncologyGastroenterologyPathologyCancer TreatmentMedicineRadiation OncologyPhase 1
| Year | Citations | |
|---|---|---|
Page 1
Page 1